For related articles and more information, please visit OCA’s Health Issues page.

The Green Shadow Cabinet, launched in spring 2013, is led by 2012 Green Party presidential nominee Jill Stein. Its purpose is to provide an ongoing opposition and alternative voice to the dysfunctional U.S. government — and to demonstrate what a government of, by, and for the people (rather than of, by, and for, giant corporations) looks like. As the Green Shadow Cabinet’s Assistant Secretary of Health for Clinical Mental Health, my first action is to propose a Mental Health Declaration of Independence from Big Pharma. I invite a public reaction to this declaration, which is both abolitionist and restorational:

(1) abolishing the corruption by giant drug companies of mental health institutions, research, and practice; and

(2) exhuming buried truths about the relationship between a dehumanized society and emotional suffering.

Abolishing the Corruption by Big Pharma of Mental Health Institutions, Research, and Practice

In what has become a “psychiatric-pharmaceutical industrial complex,” giant drug companies have corrupted mental health institutions, research, and practice. Most major mental health organizations and institution from which the general public and doctors receive information are financially interconnected with Big Pharma. This practice needs to be abolished by law.

The official psychiatric diagnostic bible that is published by the American Psychiatric Association (APA) is called the
Diagnostic and Statistical Manual of Mental Disorders (DSM). DSM-5 was recently approved by the APA, and according to the journal
PLOS Medicine, “69% of the
DSM -5 task force members report having ties to the pharmaceutical industry.” The corruption of the APA by Big Pharma is nothing new. On July 12, 2008, the New York Times reported the following about APA “In 2006, the latest year for which numbers are available, the drug industry accounted for about 30 percent of the association’s $62.5 million in financing.” Congressional investigators in 2008 also discovered that then president-elect of the American Psychiatric Association (Alan Schatzberg of Stanford University) had $4.8 million stock holdings in a drug development company.

The APA’s recently approved DSM-5 is an embarrassment even for some psychiatrists who had taken seriously previous DSM editions. Psychiatrist Allen Frances, former chair of the DSM-4 taskforce and currently professor emeritus at Duke, wrote in “Last Plea To DSM-5: Save Grief From the Drug Companies, “Making grief a mental disorder will be a bonanza for drug companies, but a disaster for grievers. . . .Psychiatry should not be mislabeling the normal.”

Most mental health professional organizations that are not on the take from Big Pharma are opposing DSM-5. The Coalition for DSM-5 Reform is comprised of over 50 organizations including the Society for Humanistic Psychology (one of several divisions of the American Psychological Association that are in the coalition), the British Psychological Society, the Danish Psychological Association, the Association of Black Psychologists, the Association for Women in Psychology, Psychologists for Social Responsibility, and the International Society for Ethical Psychology and Psychiatry.

Within the psychiatric-pharmaceutical industrial complex, there is a government-industry revolving door of employment, a staple of industrial complexes. As I detailed in 2008 in “Psycho-Pharmaceutical Industrial Complex,” there has been a revolving-door of employment between giant pharmaceutical corporations and the U.S. Food and Drug Administration (FDA), as well as with the National Institute of Mental Health (NIMH). This makes it easier for Big Pharma to create and corrupt psychiatry “thought leaders.”

Perhaps psychiatry’s most influential thought leader is Harvard psychiatrist Joseph Biederman, who  ” single-handedly put pediatric bipolar disorder on the map, ” according to pediatrician and author Lawrence Diller. Biederman’s financial relationships with drug companies was discovered by the public in 2008, when the
New York Times reported the following about him: “A world-renowned Harvard child psychiatrist whose work has helped fuel an explosion in the use of powerful antipsychotic medicines in children earned at least $1.6 million in consulting fees from drug makers from 2000 to 2007 but for years did not report much of this income to university officials.” As part of legal proceedings, Biederman was forced to provide documents about his interactions with Johnson & Johnson, the giant pharmaceutical company ; t he
New York Times reported Biederman pitched Johnson & Johnson that his proposed research studies on its antipsychotic drug Risperdal would turn out favorably for Johnson & Johnson — and then Biederman delivered the goods.

Due in great part to Biederman’s influence, the number of American children and adolescents treated for bipolar disorder increased 40-fold from 1994 to 2003.
Bloomberg News reported in 2007 , “The expanded use of bipolar as a pediatric diagnosis has made children the fastest-growing part of the $11.5 billion U.S. market for antipsychotic drugs,” and t oday this market has grown to $18 billion.

Biedeman is not alone among psychiatrists lining their pockets with drug company money. The
New York Times (“Top Psychiatrist Didn’t Report Drug Makers’ Pay”) reported this about Charles Nemeroff: “One of the nation’s most influential psychiatrists earned more than $2.8 million in consulting arrangements with drug makers from 2000 to 2007, failed to report at least $1.2 million of that income to his university and violated federal research rules, according to documents provided to Congressional investigators.”

A 2008 Congressional investigation revealed a widespread financial interconnection between Big Pharma and psychiatric institutions and thought leaders. Unfortunately, the U.S. Congress has a history of occasionally exposing the corruption of a major industrial complex but then doing nothing about it; a nd this has been the case with Congress and the psychiatric-pharmaceutical industrial complex.

What needs to be done? Let’s start by throwing out
everything that has been created by Big Pharma corrupted mental health institutions and thought leaders. And let’s begin a “Mental Health Enlightenment” based on genuine science, which would mean an admission of exactly what psychiatrists and psychologists do and do not know.